SEGMENT REPORTING (Tables)

3 Months Ended

Mar. 31, 2025

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The following table reflects results of operations of the Company’s reportable segment (in thousands):

	Three Months Ended March 31,
	2025		2024
Infusion services net revenue	$	1,311,181	$	1,125,662
Other revenue (1)	21,791		20,390
Total Option Care Health revenue	1,332,972		1,146,052
(Expense) Income:
Cost of net revenues - drugs	(933,068)		(777,260)
Salaries, benefits, and other employee expense	(205,692)		(191,815)
Other segment items (2)	(99,278)		(93,219)
Depreciation and amortization expense	(15,746)		(14,728)
Interest expense, net	(13,231)		(13,202)
Equity in earnings of joint ventures	1,729		1,125
Other, net	(4,130)		2
Income tax expense	(16,814)		(12,164)
Net Income	$	46,742	$	44,791

(1) Represents business activities related to other miscellaneous revenue streams.

(2) Other segment items includes expenses for medical supplies, delivery and packaging, leases, professional services, and other expenses.